Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
Small molecule c-Myc inhibitors
US11066398B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11066398-B2 |
| Application number | US-201415035842-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 10, 2014 |
| Priority date | Dec 11, 2013 |
| Publication date | Jul 20, 2021 |
| Grant date | Jul 20, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention provides small molecule Myc-inhibitors. Also provided in the invention are therapeutic applications of these compounds for treating Myc-driven cancer and other related methods.
First claim
Opening claim text (preview).
We claim: 1. A method of treating c-Myc driven cancer, comprising administering an effective amount of 4-(2-(furan-2-yl)-6-(4-nitrophenyl)pyridin-4-yl)benzamide (CG-RS-44).
Assignees
Inventors
Classifications
Antineoplastic agents · CPC title
having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine · CPC title
Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals · CPC title
Non condensed pyridines; Hydrogenated derivatives thereof · CPC title
- C07D413/14Primary
containing three or more hetero rings · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11066398B2 cover?
- This invention provides small molecule Myc-inhibitors. Also provided in the invention are therapeutic applications of these compounds for treating Myc-driven cancer and other related methods.
- Who is the assignee on this patent?
- Scripps Research Inst, Sorrento Therapeutics, Vogt Peter K, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification C07D413/14. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).